Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 32.45
+0.65 (2.04%)
At close: Dec 26, 2025
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.52 billion as of December 26, 2025. Its market cap has decreased by -7.81% in one year.
Market Cap
4.52B
Enterprise Value
6.34B
Revenue
1.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.45
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.52B, an increase of 560.35%. That is a compound annual growth rate of 9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 4.52B | 0.15% |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | 8.23B | -4.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 244.27B |
| PharmaEssentia | 181.23B |
| Heron Neutron Medical | 75.90B |
| Lotus Pharmaceutical | 73.24B |
| Bora Pharmaceuticals Co., LTD. | 61.08B |
| Lin BioScience | 33.09B |
| Lumosa Therapeutics | 31.08B |
| Oneness Biotech | 27.75B |